ArticleYonsei medical journal2020

mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.

Ji Young Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.